Radar > 361189

Altamar Capital Partners launches ABV II in partnership with Aliath Bioventures to invest in healthcare companies for EUR 150m

Altamar Capital Partners lanza ABV II en alianza con Aliath Bioventures para invertir en empresas de salud por EUR 150m

Intel ID : 361189

Relevant Documents


Intel ID 361189
Value EUR 150,00m
Native Currency Euro (EUR)
Date
Country
Geography
Subsector (Old TTR Sectors)
Primary Subsector (TTRSC)
25.01.01 Asset Management (Primary)
25 Financial Services / 25.01 Banking & Investment

25.01.09 Private Equity (Primary)
25 Financial Services / 25.01 Banking & Investment

10.01.02 Consulting & Professional Development Services (Primary)
10 Business Services / 10.01 Business & Professional Support Services

Secondary Subsectors (TTRSC)
25.01.10 Venture Capital
25 Financial Services / 25.01 Banking & Investment

Type
Intel Grade
Source
Tags

Bidder

Name
verified
Subsector (Old TTR Sectors)
Services and Distribution / Financial and Insurance (Primary)
Primary Sector (TTRSC)
25.01.01 Asset Management
25 Financial Services / 25.01 Banking & Investment

Country
Description

Ultimate Owner (Buyer)

Name
verified
Subsector (Old TTR Sectors)
Services and Distribution / Consultancy, Audit and Engineering (Primary)
Primary Sector (TTRSC)
10.01.02 Consulting & Professional Development Services
10 Business Services / 10.01 Business & Professional Support Services

Country
Description

Ultimate Owner (Buyer)

Name
verified
Subsector (Old TTR Sectors)
Services and Distribution / Financial and Insurance (Primary)
Primary Sector (TTRSC)
25.01.09 Private Equity
25 Financial Services / 25.01 Banking & Investment

Country
Website
Description

Legend:

verified Verified: Confirmed as a party to an active or possible transaction.

potential Potential: Unconfirmed as a party to an active or possible transaction.

retained Retained: Confirmed as “Retained” with a general or specific mandate.

prospect Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.

Transactional data is continuously updated by the research team and therefore is subject to change.